|Articles|October 14, 2020

Sarah Michelle Gellar shares her family's experience with myopia

Author(s)Brooke Henson, Editor, Gretchyn M. Bailey, NCLC, FAAO, Editor in Chief, Content Channel Director

Actress, producer, and entrepreneur Sarah Michelle Gellar chats with Optometry Times® editors Brooke Beery and Gretchyn M. Bailey, NCLC, FAAO, about myopia management. Gellar is spokesperson for CooperVision's Brilliant Futures myopia management program. She discusses screen use and her children, her son's foray into myopia management, and the importance of ODs communicating with patients the options around myopic correction.

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Sarah Michelle Gellar shares her family's experience with myopia

Related Content

Practical tips and tricks: Drs Jeffrey J. Walline, Erin Tomiyama weigh in on myopia management

TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis

Recent study findings may prove previous estimations of retinal cell communication, low-light vision

Hybrid AI model distinguishes keratoconus from healthy eyes with 90% accuracy

Georgia university receives state funding for state's first college of optometry

Latest CME

(COPE Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

Neurotrophic Keratitis Insights: An Interactive Corneal Sensitivity Testing Workshop

(CME Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

(COPE Credit) Navigating Pharmacological Presbyopia Treatment for Enhanced Patient Care

(CME Track) Small Mites, Big Impact: Revolutionizing Demodex Blepharitis Care

Retina Updates in Montréal

PER Global Perspectives: The TROP2-Targeted ADC Landscape in NSCLC and How to Interpret the Evidence

Rapid Reviews in Retina™: Emerging Updates from Spring 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Interventional Dry Eye: A Stepwise Treatment & Management Approach

(CME Track) Community Collaborative Connections™: Optimizing the Collaborative Care of Neovascular Retinal Disease in a New Age of Treatment

(CME Track) Collaborating Across the Continuum™: Best Practices in Patient-Centric Team Management of XLRP

(CME Track) Rapid Reviews in Retina™: Emerging Updates from Summer 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

(CME Track) A Forward Look at Anti-VEGF Therapies: A Paradigm Shift in Neovascular Retinal Disease Management

(CME Track) The Evolution of MacTel Management: Integrating Neuroprotective Therapies Into Clinical Practice

Navigating Advances in Neovascular Retinal Disease: Translating Evidence to Practice in AMD, DME, and RVO

(CME Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

(COPE Track) Beyond the Collarette: Empowering Patients in the Management of Demodex Blepharitis

Navigating Ocular Toxicities: A Multidisciplinary Roadmap for Managing Adverse Events in Targeted Cancer Therapy

Rapid Reviews in Retina™: Emerging Updates from Fall 2025—Addressing the Wealth of New Data in Treatments for Neovascular Retinal Disease

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis

Georgia university receives state funding for state's first college of optometry

Recent study findings may prove previous estimations of retinal cell communication, low-light vision

Exercise for the prevention and mitigation of eye disease

Hybrid AI model distinguishes keratoconus from healthy eyes with 90% accuracy